MENU
IKNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ikena Oncology (IKNA) Ownership - Who owns Ikena Oncology?
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network... Show more
Profile
Industry
N/A
Address
645 Summer Street
Phone
+1 857 273-8343
Employees
43
Web
https://www.ikenaoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
64.67M
P/E Ratio
N/A
Total Cash
114.05M
Projected Growth
N/A
Total Debt
6.61M
Revenue
N/A
Risk (Beta)
0.10
Dividend Yield
N/A
Total Cash/Share
2.36
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IKNA
Capitalization
64.7M
P/E Ratio
N/A
Risk (Beta)
0.10
Dividend Yield
N/A
Total Cash
114M
Total Cash/Share
2.36
Total Debt
6.61M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
118M
P/B Ratio
0.55
Cash Flow
N/A
Earnings
-0.87
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
48K
Current Ratio
13.31
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-47.91M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.47
Shares Held By Institutions
36.4M
Shares Outstanding - Current
48.3M
Total Liabilities
12.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-18.293
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
645 Summer Street
Phone
+1 857 273-8343
Employees
43
Web
https://www.ikenaoncology.com